CORD-19:12d35c12218f230c49f4dc892814ba9f1037f251 / 58371-58598 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T39","span":{"begin":0,"end":227},"obj":"Sentence"}],"text":"Therefore, targeting OX40 during priming of VACV-specific CD8 T cells elicits fully protective and long-lived anti-viral CD8 T cell responses in the lung irrespective of the site of vaccination and the context of viral antigen."}

{"project":"CORD-19-Sentences","denotations":[{"id":"T94428","span":{"begin":0,"end":227},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Therefore, targeting OX40 during priming of VACV-specific CD8 T cells elicits fully protective and long-lived anti-viral CD8 T cell responses in the lung irrespective of the site of vaccination and the context of viral antigen."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T82","span":{"begin":149,"end":153},"obj":"Body_part"}],"attributes":[{"id":"A82","pred":"uberon_id","subj":"T82","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"Therefore, targeting OX40 during priming of VACV-specific CD8 T cells elicits fully protective and long-lived anti-viral CD8 T cell responses in the lung irrespective of the site of vaccination and the context of viral antigen."}